Sep 20, 2017
After stops and starts, successes and disappointments, point-of-care diagnostic testing (POCT) has finally come of age. From its humble beginnings in the 1990’s, POCT has become a $16 billion market, delivering value to patients, caregivers and investors. As a...
Sep 13, 2017
Over the past years, I have had the fortune of participating in negotiations and ultimate deals between Western and Japanese biopharmaceutical companies. Doing deals is never easy, no matter the geography. However, it does seem that negotiating with Japanese companies...
Aug 29, 2017
With the new school year just around the corner here in Boston (and already underway in other parts of the country), transactions involving academic and research institutions are on our minds. Specifically, while research doesn’t stop during the summer vacation, as...
Aug 23, 2017
At different stages of development, entrepreneurs attempt to gain insight into the value of their technology to make strategic decisions about which paths to pursue (M&A, Fundraising, etc.). The medical technology space can be particularly difficult in this...
Aug 15, 2017
A few months ago, I posted a related article about deal timing titled ‘Maintaining Deal Momentum in the Summer Months’. Now it is early August, and we are deep in the summer slowdown. Many of us are enjoying the last stints of our summer holidays before returning to...
